Skip to main content
search
HomeGlobal Presence › Bahrain
India → Bahrain

Pharmaceutical Exporter to Bahrain from India

Indian Generic Medicines (IGM) is a WHO-GMP-aligned, DGFT-registered pharmaceutical exporter to Bahrain from India — supplying NHRA-registered generics, oncology, antibiotics, antivirals and vaccines to licensed importers, hospitals and distributors, with full export documentation.

WHO-GMP
WHO-GDP
GMP / EU-GMP
PIC/S
US FDA
NHRA
National Health Regulatory Authority
Manama
Compact GCC market
Quality
Quality-focused sector
IndiaBahrain
WHO-GMPEU-GMPUS FDA-approved sourcesDGFT RegisteredNHRA-Ready DocsCold-Chain LogisticsEst. 2014
Quick answer

Can Indian companies export medicines to Bahrain?

In short

Yes — Indian companies can export medicines to Bahrain once the product is registered with the National Health Regulatory Authority (NHRA) and imported through a Bahrain-licensed importer. Products should be WHO-GMP made, with a CPP, COA, GMP certificate and Certificate of Origin. Bahrain is supplied through Khalifa Bin Salman Port and Bahrain International Airport.

RequirementBahrain
Medicines regulatorNHRA (National Health Regulatory Authority)
Product registrationRequired before marketing
Certificate of Pharmaceutical Product (CPP)Yes
WHO-GMP manufacturingRequired
Cold chainRequired for temperature-sensitive medicines
Main entry pointKhalifa Bin Salman (sea); BAH (air)
Local importer licenceYes — NHRA-licensed importer
Regulations

Medicine export regulations for Bahrain (NHRA)

Bahrain’s medicines are regulated by the National Health Regulatory Authority (NHRA). Imported medicines must be registered with the NHRA and brought in through a licensed local importer, with WHO-GMP as the benchmark. Bahrain has a compact, quality-focused healthcare market.

Documents required

DocumentPurpose
Certificate of Pharmaceutical Product (CPP)Confirms the product’s regulatory status in India (WHO format).
Certificate of Analysis (COA)Confirms quality and composition of each batch.
GMP CertificateConfirms the site meets Good Manufacturing Practice standards.
Certificate of OriginConfirms manufacture in India.
Commercial invoice & packing listRequired for customs clearance.
Export process

How to export medicine from India to Bahrain — step by step

Choose a certified, DGFT-registered Indian exporterWHO-GMP-aligned, able to provide NHRA-compatible documentation.
Define your product requirementsCategory, INN or brand, dosage form, strength, pack size and quantity.
NHRA registration via your local importerYour licensed importer registers the product using the exporter’s documentation.
Documentation & proforma invoiceCPP, COA, GMP certificate and Certificate of Origin prepared for customs.
Shipping & cold chainVia Khalifa Bin Salman Port or air freight to Bahrain International Airport; sea freight roughly 1–2 weeks; air freight about 3–4 days. Temperature-sensitive products ship monitored.
Customs clearance & deliveryYour clearing agent processes the consignment; complete documentation ensures smooth clearance.
Medicine categories

Medicine categories exported from India to Bahrain

Generic & branded medicinesWHO-GMP tablets, capsules, syrups and injectables across dozens of categories.
ARVs, anti-malarials & antibioticsAntiretrovirals, anti-malarials and a broad anti-infective range for public-health programmes.
Oncology drugsChemotherapy agents and targeted therapies with NHRA-compatible documentation.
Cardiac & diabetes medicinesAntihypertensives, statins, anticoagulants and antidiabetics for chronic-disease demand.
Antivirals & hepatitis therapiesAntiviral and hepatitis treatments available for export.
Vaccines & biologics (cold chain)Temperature-controlled logistics preserve potency from India to Bahrain.
Logistics & cold chain

Logistics & cold chain to Bahrain

Shipments move via Khalifa Bin Salman Port or air freight to Bahrain International Airport — sea freight roughly 1–2 weeks; air freight about 3–4 days. Temperature-sensitive products (vaccines, biologics and certain injectables) are shipped under validated cold-chain packaging with real-time temperature monitoring to preserve potency from India to Bahrain, in line with WHO-GDP good distribution practice.

FAQ

Frequently asked questions

Yes. Indian exporters can supply Bahrain once the product is registered with the NHRA and imported through a licensed local importer, with WHO-GMP manufacturing and full documentation.

Generally yes — medicines must be registered with the NHRA before marketing. The Bahraini importer arranges registration using the exporter’s documentation.

CPP, COA, GMP certificate, Certificate of Origin, commercial invoice and packing list.

The National Health Regulatory Authority (NHRA).

Bahrain imports most of its medicines; India offers WHO-GMP quality at competitive prices across a broad range.

Generics across major categories, oncology drugs, antibiotics, antivirals, cardiac and diabetes formulations, and cold-chain vaccines.

By sea to Khalifa Bin Salman Port, roughly 1–2 weeks, or by air to Bahrain International Airport, about 3–4 days. Cold-chain products ship temperature-monitored.

Ask for the Pharmexcil RCMC, IEC, drug licence and WHO-GMP certificates. IGM provides these on request.

Why IGM

Why choose Indian Generic Medicines for Bahrain

Experience since 2014A wholesaler and exporter serving Bahrain, Africa and beyond.
DGFT registeredWorking with WHO-GMP, GMP and ISO-certified manufacturing partners.
Full documentationCOA, CPP, GMP certificate and Certificate of Origin with every shipment.
NHRA-ready supportDocumentation aligned to Bahrain’s NHRA requirements, coordinated with your importer.
Wide portfolioGenerics, oncology, antibiotics, antivirals, cardiac, diabetes and vaccines.
Dedicated export supportFrom inquiry and proforma invoice through logistics and post-shipment.
Get started

Source certified medicines from India for Bahrain

Share your therapeutic list, quantities and registration status — we’ll respond with NHRA-ready documentation, pricing and logistics options.

NG
Written by
Nitin Goswami
Pharmaceutical export & regulatory content, Indian Generic Medicines (IGM)
SB
Reviewed by
Shilpi Banerjee
Content & compliance review, Indian Generic Medicines (IGM)
Last reviewed on 01 July 2026 · Published by Indian Generic Medicines (IGM), established 2014
Close Menu
WhatsApp Email Phone